Cargando…

In vivo/In vitro immune responses to L. major isolates from patients with no clinical response to Glucantime

BACKGROUND: Leishmaniasis is a major health problem in some endemic areas of tropical and subtropical areas of the world. Interleukin-12 (IL-12) and interferon gamma (IFN-γ) are essential cytokines associated with initiation of Th1 response. The main objective of this study was to evaluate of the ty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saberi, Sedigheh, Arjmand, Reza, Soleimanifard, Simindokht, Khamesipour, Ali, Hosseini, Seyed Mohsen, Salehi, Mansoor, Varshosaz, Jaleh, Palizban, Abbas Ali, Hejazi, Seyed Hossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976526/ https://www.ncbi.nlm.nih.gov/pubmed/27563636 http://dx.doi.org/10.4103/2277-9175.187000

Ejemplares similares

P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER)
por: SOLEIMANIFARD, Simindokht, et al.
Publicado: (2014)

Treatment Outcome of the Drug-resistant Zoonotic Cutaneous Leishmaniasis by Glucantime
por: Soleimanifard, Simindokht, et al.
Publicado: (2017)

Antigenic profile of heat-killed versus thimerosal-treated Leishmania major using sodium dodecyl sulfate-polyacrylamide gel electrophoresis
por: Arjmand, Reza, et al.
Publicado: (2015)

Identification of etiologic agents of cutaneous Leishmaniasis in palpebral position followed by effective therapy
por: Saberi, Sedigheh, et al.
Publicado: (2017)

The therapeutic effect of ozonated olive oil plus glucantime on human cutaneous leishmaniasis
por: Aghaei, Maryam, et al.
Publicado: (2019)

Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica: study protocol for a randomized, controlled trial
por: Eskandari, Seyed Ebrahim, et al.
Publicado: (2021)

Anti-Leishmania Activity of Osthole
por: Kermani, Elaheh Kordzadeh, et al.
Publicado: (2016)

Identification of Leishmania isolates from Varzaneh city, Isfahan province, Iran using nested polymerase chain reaction method
por: Arjmand, Reza, et al.
Publicado: (2014)

Efficacy of adjunctive topical liposomal clarithromycin on systemic Glucantime in Old World cutaneous leishmaniasis: a pilot clinical study
por: Hakamifard, Atousa, et al.
Publicado: (2023)

Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites
por: Hadighi, Ramtin, et al.
Publicado: (2006)

A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions
por: Jaffary, Fariba, et al.
Publicado: (2016)

A Survey on Inhibitory Effect of Whole-Body Extraction and Secretions of Lucilia sericata's Larvae on Leishmania major In vitro
por: Tahmasebi, Maryam, et al.
Publicado: (2020)

Sphingomyelin Liposomes Containing Soluble Leishmania major antigens Induced Strong Th2 Immune Response in BALB/c Mice
por: Chavoshian, Omid, et al.
Publicado: (2013)

In vitro activity of Alkanna frigida extracts in comparison with glucantime against Leishmania major
por: Jafari, Fariba, et al.
Publicado: (2013)

Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis
por: ZAREAN, Mehdi, et al.
Publicado: (2015)

Downregulation of Calcineurin Gene Is Associated with Glucantime(®) Resiatance in Leishmania infantum
por: Bagher KHADEM ERFAN, Mohammad, et al.
Publicado: (2013)

Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis
por: Iranpour, Sohrab, et al.
Publicado: (2019)

Gulucatime versus Glucantime: A Serious Warning on Counterfeit Medicines
por: Abtahi-Naeini, Bahareh, et al.
Publicado: (2019)

Evaluation of Different Concentrations of Imatinib on the Viability of Leishmania major: An In Vitro Study
por: Moslehi, Mohsen, et al.
Publicado: (2019)

Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major
por: Hoseini, Shervin Ghaffari, et al.
Publicado: (2014)

The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major
por: Jaffary, Fariba, et al.
Publicado: (2014)

In vitro and in vivo Anti‐Toxoplasma activity of Dracocephalum kotschyi essential oil
por: Khamesipour, Faham, et al.
Publicado: (2020)

Effect of integrated pest management on controlling zoonotic cutaneous leishmaniasis in Emamzadeh Agha Ali Abbas (AS) District, Isfahan province, 2006-2009
por: Nilforoushzadeh, Mohammad Ali, et al.
Publicado: (2014)

First Report on Infant Acute Urticaria after Mother’s Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report
por: MOZAFARI, Omid, et al.
Publicado: (2016)

Purification of lactoperoxidase from bovine whey and investigation of kinetic parameters
por: Borzouee, Fatemeh, et al.
Publicado: (2016)

Study of therapeutic effect of different concentrations of imatinib on Balb/c model of cutaneous leishmaniasis
por: Moslehi, Mohsen, et al.
Publicado: (2020)

Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis
por: Nilforoushzadeh, Mohammad Ali, et al.
Publicado: (2007)

Preparation, Optimization, and Screening of the Effect of Processing Variables on Agar Nanospheres Loaded with Bupropion HCl by a D-Optimal Design
por: Varshosaz, Jaleh, et al.
Publicado: (2015)

Comparison of Intralesional Two Percent Zinc Sulfate and Glucantime Injection in Treatment of Acute Cutaneous Leishmaniasis
por: Maleki, Masoud, et al.
Publicado: (2012)

Effect of transgenic Leishmania major expressing mLLO-Bax-Smac fusion gene in the apoptosis of the infected macrophages
por: Aghaei, Maryam, et al.
Publicado: (2021)

Optimization of Poly(methyl vinyl ether-co-maleic acid) Electrospun Nanofibers as a Fast-Dissolving Drug Delivery System
por: Varshosaz, Jaleh, et al.
Publicado: (2018)

Poly (ethylene-co-vinyl alcohol)-based polymeric thermo-responsive nanocarriers for controlled delivery of epirubicin to hepatocellular carcinoma
por: Hassanzadeh, Farshid, et al.
Publicado: (2017)

DECREASED EFFECT OF GLUCANTIME IN CUTANEOUS LEISHMANIASIS COMPLICATED WITH SECONDARY BACTERIAL INFECTION
por: Sadeghian, G, et al.
Publicado: (2011)

Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to Leishmania major
por: Hoseini, Shervin G., et al.
Publicado: (2012)

Immune response in cutaneous leishmaniasis patients with healing vs. non-healing lesions
por: Miramin-Mohammadi, Akram, et al.
Publicado: (2020)

Evaluation of Immune Response against Leishmaniasis in BALB/c Mice Immunized with Cationic DOTAP/DOPE/CHOL Liposomes Containing Soluble Leishmania major Antigens
por: HOJATIZADE, Mansure, et al.
Publicado: (2019)

An innovative cell selection approach in developing human cells overexpressing aspartyl/asparaginyl β-hydroxylase
por: Bakhtiari, Hadi, et al.
Publicado: (2020)

Aptamer-based approaches for in vitro molecular detection of cancer
por: Bakhtiari, Hadi, et al.
Publicado: (2020)

Novel Approach to Overcome Defects of Cell-SELEX in Developing Aptamers against Aspartate β-Hydroxylase
por: Bakhtiari, Hadi, et al.
Publicado: (2021)

Improvement of the Solubility Amphotericin B Using Olive Oil Nanoemulsion Coated with Chitosan for More Effective Treatment of Zoonotic Cutaneous Leishmaniasis
por: Taghizadeh, Elnaz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_19j9ptbiljn7ebe7c6i0mfm65v